These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5625994)

  • 1. [Pharmacological investigation of hydrotalcite, synthetized gastric antacid, its toxicity and effect on the experimental gastric ulcer].
    Hara S; Hirayama H; Itabashi H; Kikuta K; Sato S
    Zasshi Tokyo Ika Daigaku; 1967 Sep; 25(5):695-728. PubMed ID: 5625994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological investigation of a new synthesized antacid-Hydrotalcite (H-505) and its related substances. Investigation of their influence on artificial gastric juice and experimental gastric ulcer].
    Hara S; Hirayama H; Itabashi H; Sasaki Y; Matsushima Y
    Zasshi Tokyo Ika Daigaku; 1968 Mar; 26(1):211-26. PubMed ID: 5692514
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antacid effect of colloidal aluminum phosphate (Phosphalugel). Intragastric acidity examinations by means of the Heidelberg capsule and clinical bedside experiences].
    Ranft M; Nöller HG
    Munch Med Wochenschr; 1965 Sep; 107(38):1830-2. PubMed ID: 5323497
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-ulcer and antacid activity of a new cyclopentane substance].
    Rosini S; Trallori L; Benetti D
    Farmaco Prat; 1976 Aug; 31(8):426-35. PubMed ID: 955056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antacid therapy of peptic ulcer].
    Fisher AA
    Klin Med (Mosk); 1969 Apr; 47(4):43-8. PubMed ID: 5371486
    [No Abstract]   [Full Text] [Related]  

  • 6. Antacid therapy for duodenal and gastric ulcer: the experience in the United States.
    Ippoliti AF
    Scand J Gastroenterol Suppl; 1982; 75():82-5. PubMed ID: 6755655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutralization capacity of antacids].
    Holtermüller KH; Herzog P; Hissnauer KH; Kühl HJ; Walther C
    Z Gastroenterol; 1981 Nov; 19(11):725-7. PubMed ID: 7314757
    [No Abstract]   [Full Text] [Related]  

  • 8. Antacid pharmacology in duodenal ulcer. Effect of antacids on postcibal gastric acidity and peptic activity.
    Fordtran JS; Collyns JA
    N Engl J Med; 1966 Apr; 274(17):921-7. PubMed ID: 5908884
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative evaluation of the antacid properties of the preparations Maalox and Almagel].
    Grebenev AL; Sheptulin AA; Okhlobystin AV
    Ter Arkh; 1994; 66(8):44-7. PubMed ID: 7985154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional antacid does not increase the effect of cimetidine in gastric ulcer disease.
    Rune SJ; Jensen KG; Wulff HR; Bendtsen F; Lindskov J; Mejer J; Højlund M; Nissen VR; Willumsen L; Agner E
    Scand J Gastroenterol; 1984 Jan; 19(1):56-8. PubMed ID: 6369522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antacid on gastric and duodenal bulb acidity.
    Hannibal S; Remvig L; Rune SJ
    Scand J Gastroenterol Suppl; 1980; 58():29-36. PubMed ID: 6929092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pepsin-forming function of the stomach in patients with peptic ulcer in relation to the stage of the disease and Almagel treatment].
    Samson EI; Iaroma MS
    Klin Med (Mosk); 1971 Oct; 49(10):53-6. PubMed ID: 4943767
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional cytoprotection by certain antacids.
    Szelényi I
    Acta Physiol Hung; 1984; 64(3-4):259-68. PubMed ID: 6598001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with vanamil, a new antacid.
    Riegel N
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):161-9. PubMed ID: 4985495
    [No Abstract]   [Full Text] [Related]  

  • 15. [A layered lattice antacid with long-term effectiveness. Profile of action and safety exemplified by magaldrate].
    Kurtz W
    Fortschr Med; 1993 Feb; 111(6):93-6. PubMed ID: 8462913
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast) and its components against ulcers and rebound acidity.
    Khayyal MT; Seif-El-Nasr M; El-Ghazaly MA; Okpanyi SN; Kelber O; Weiser D
    Phytomedicine; 2006; 13 Suppl 5():56-66. PubMed ID: 16963243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpromazine in experimental gastric ulcers induced by restraint and cold stress.
    Canver CC
    N Y State J Med; 1985 Mar; 85(3):101-2. PubMed ID: 3857475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medication neutralizing gastric acidity and protecting the gastric mucosa].
    Meeroff M; Maggi LC
    Medicina (Mex); 1965 Jun; 45(965):253-61 contd. PubMed ID: 5844498
    [No Abstract]   [Full Text] [Related]  

  • 19. Antacid therapy and the gastric mucosal barrier.
    Dill JE
    Gastroenterology; 1972 Apr; 62(4):697. PubMed ID: 5020882
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Brazilian green propolis on experimental gastric ulcers in rats.
    de Barros MP; Sousa JP; Bastos JK; de Andrade SF
    J Ethnopharmacol; 2007 Apr; 110(3):567-71. PubMed ID: 17126509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.